Please provide your email address to receive an email when new articles are posted on . Transcatheter aortic valve replacement was noninferior to surgery for death and stroke at 1 year in a real-world ...

WASHINGTON, DC — New European registry data on transcatheter aortic-valve replacement (TAVR) in patients at lower surgical risk than those studied in the pivotal randomized trials offers the ...

Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...

A risk model allowing cardiologists and their patients to share decision-making about undergoing surgery after transcatheter aortic valve replacement (TAVR) had received high marks for its accuracy in ...

SAN FRANCISCO -- A handful of years later, transcatheter aortic valve replacement (TAVR) still compared well against surgery in the PARTNER 3 and Evolut Low Risk trials. PARTNER 3 appeared to show a ...

Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...

To inform heart team and patient decision-making on valve surgery, The Society of Thoracic Surgeons (STS) has launched new risk calculators for isolated tricuspid valve repair and replacement; ...

High-risk surgical patients with severe aortic stenosis who underwent a transcatheter aortic valve replacement experienced higher one-year survival rates than patients who underwent traditional ...

CHICAGO -- Transcatheter aortic valve replacement (TAVR) continued to hold its own against surgery for younger patients at low surgical risk, with the Evolut Low Risk trial now halfway to its goal of ...

Intermediate-risk patients who received transcatheter aortic valve replacement, known as TAVR, with the latest-generation valve fared better than patients receiving traditional surgical aortic valve ...